Bob Lea
Medicines Supply Chain Leader
Ware UK
3D remodelled DNA helix structure
About us We want to help people do more, feel better, live longer.
Today there are still millions of people without access to basic healthcare, thousands of diseases without adequate treatments and millions more people who suffer from everyday ailments. At GSK we want to change this.
Read morePress releases
- GSK and Innoviva report positive headline results from IMPACT study showing single inhaler triple therapy Trelegy Ellipta reduced COPD exacerbations
- Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US
- Trelegy Ellipta once-daily single inhaler triple therapy receives positive opinion from the CHMP in Europe for appropriate patients with COPD
Tweets from GSK
-
GSK @GSK
How can we make #health4all a reality? More innovative, ambitious and scalable partnerships:… twitter.com/i/web/status/9…
about 2 hours ago -
GSK @GSK
The future of vaccines: come #BehindTheScience to find out what we’re working on: gsk.to/2fAjcTO #FridayReads
about 4 hours ago -
GSK @GSK
We’re partnering with @savechildrenuk, @AmrefWorldwide @CARE @earthinstitute to train healthcare workers and help a… twitter.com/i/web/status/9…
about 5 hours ago
